SCHEMBL7001348

SCHEMBL7001348

CC(=O)Nc1ccc(C)cc1C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.67
HSD17B10 Q99714 1/20 0.67
KMT2A Q03164 4/20 0.64
MEN1 O00255 3/20 0.64
GFER P55789 1/20 0.64
PPARG P37231 1/20 0.57
PPARA Q07869 1/20 0.57
ALDH1A1 P00352 4/20 0.55
MAPT P10636 1/20 0.55
HTT P42858 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
METAP2 P50579 2/20 0.54
ABCC1 P33527 1/20 0.54
CSNK2A1 P68400 1/20 0.53
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA4 P22748 1/20 0.52
CA7 P43166 1/20 0.52
PLK1 P53350 6/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4839372 0.89 MEN1 (0.68) KDM4EHSD17B10KMT2AMEN1GFER
SCHEMBL14822784 0.87 KMT2A (0.53) KDM4EHSD17B10KMT2AMEN1GFER
SCHEMBL6891543 0.85 KMT2A (0.55) KDM4EHSD17B10KMT2AMEN1GFER
SCHEMBL14400504 0.84 HPGD (0.68) KMT2AMEN1GFERPPARGPPARA
SCHEMBL7850074 0.84 PTPN1 (0.65) KMT2AMEN1GFERPPARGPPARA
SCHEMBL14426494 0.83 MEN1 (0.66) KMT2AMEN1GFERALDH1A1MAPT
SCHEMBL31451940 0.83 KDM4E (0.69) KDM4EHSD17B10KMT2AMEN1GFER
SCHEMBL8533041 0.83 KDM4E (0.69) KDM4EHSD17B10KMT2AMEN1GFER
SCHEMBL8340439 0.82 MEN1 (0.60) KMT2AMEN1GFERPPARGPPARA
SCHEMBL11803827 0.81 KDM4E (0.67) KDM4EHSD17B10KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101693666-A Stilbene derivative UNIV SUZHOU 2010-04-14 CN disclosed
US-20080171891-A1 Process for preparing carbamic ester derivatives HOLZER BETTINA 2008-07-17 US disclosed
US-7396952-B2 Process for preparing carbamic ester derivatives LANXESS DEUTSCHLAND GMBH (DE) 2008-07-08 US disclosed
US-20070232825-A1 Process for preparing carbamic ester derivatives LANXESS DEUTSCHLAND GMBH (DE) 2007-10-04 US disclosed
EP-0980374-B1 PHOSPHODIESTERASE 4-INHIBITING DIAZEPINOINDOLONES PFIZER HOLDING FRANCE (FR) 2003-02-12 EP disclosed
US-6239130-B1 ASTHMA, ATOPIC DERMATITIS, RHEUMATOID ARTHRITIS, INFLAMMATORY BOWEL DISORDERS, PULMONARY HYPERTENSION, LIVER INJURY, BONE LOSS, SEPTIC SHOCK, OR MULTIPLE SCLEROSIS, WARNER-LAMBERT COMPANY 2001-05-29 US disclosed
EP-0980374-A1 PHOSPHODIESTERASE 4-INHIBITING DIAZEPINOINDOLONES PARKE-DAVIS (FR) 2000-02-23 EP disclosed
WO-1998049169-A1 PHOSPHODIESTERASE 4-INHIBITING DIAZEPINOINDOLONES PARKE-DAVIS (FR) 1998-11-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171891-A1 Process for preparing carbamic ester derivatives CPS1, CA7, CA4 KDM4E 128/4885HSD17B10 718/4885KMT2A 1072/4885
US-20070232825-A1 Process for preparing carbamic ester derivatives CPS1, CA7, CA4 KDM4E 128/4885HSD17B10 718/4885KMT2A 1072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.